V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20207044 | 20077431 | 1.86 | 59.4 | Neo-adjuvant (N) | 2018-11-08 | 2018-11-24 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101860328 |
| 20207048 | 20077432 | 1.6 | 82.1 | Palliative (P) | 2017-02-02 | 2017-02-04 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101034512 |
| 20207058 | 20077433 | 1.75 | 90.3 | Palliative (P) | 2018-04-27 | 2018-05-14 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101029018 |
| 20207060 | 20077434 | 1.57 | 97.9 | Curative (C) | 2017-09-30 | 2017-09-30 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100569353 |
| 20207066 | 20077435 | 0 | 0 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-25 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 101734021 |
| 20207073 | 20077436 | null | null | 03 | 2018-12-20 | 2019-01-04 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100689110 |
| 20207075 | 20077437 | 1.67 | 80.6 | Palliative (P) | 2016-02-01 | 2016-02-21 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101316225 |
| 20207078 | 20077438 | null | null | Palliative (P) | 2016-06-19 | 2016-07-19 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101742685 |
| 20207079 | 20077439 | 0 | 0 | Neo-adjuvant (N) | 2016-12-17 | 2017-01-22 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100112174 |
| 20207083 | 20077440 | 0 | 0 | null | 2016-11-15 | 2016-11-19 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 101423543 |
| 20207088 | 20077441 | 1.78 | 79 | Palliative (P) | 2017-11-09 | 2017-11-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101631875 |
| 20207091 | 20077442 | 1.7 | null | null | 2017-12-16 | 2017-12-16 | Capecitabine (21days) + Carboplatin | 2 | N | TRIAL UNSPECIFIED | 100528638 |
| 20207094 | 20077443 | 1.6 | 53.8 | Palliative (P) | 2019-12-01 | 2019-12-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100257957 |
| 20207097 | 20077444 | 0 | 0 | Neo-adjuvant (N) | 2020-08-03 | 2020-09-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100288767 |
| 20207099 | 20077445 | 0 | 0 | Adjuvant (A) | 2016-10-31 | 2016-11-16 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101331811 |
| 20207100 | 20077446 | 1.59 | 135 | Neo-adjuvant (N) | 2017-07-19 | 2017-08-01 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101668683 |
| 20207101 | 20077447 | 1.57 | 64.8 | Neo-adjuvant (N) | 2019-11-10 | 2019-12-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101244431 |
| 20207104 | 20077448 | 1.68 | 49.3 | Neo-adjuvant (N) | 2020-02-25 | 2020-02-25 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100469647 |
| 20207114 | 20077449 | 1.63 | 57.7 | Palliative (P) | 2019-06-10 | 2019-06-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100346644 |
| 20207124 | 20077450 | 1.7 | 50.8 | Palliative (P) | 2019-02-13 | 2019-02-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101070989 |
| 20207139 | 20077451 | 0 | 0 | Curative (C) | 2017-09-24 | 2017-10-22 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101293870 |
| 20207141 | 20077452 | 1.76 | 59.35 | Palliative (P) | 2019-10-22 | 2019-11-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100750711 |
| 20207143 | 20077453 | 1.81 | 65 | Palliative (P) | 2020-03-19 | 2020-03-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100907305 |
| 20207144 | 20077454 | 0 | 0 | Curative (C) | 2019-09-10 | 2019-10-08 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100877602 |
| 20207145 | 20077455 | 1.67 | 65.4 | null | 2019-01-07 | 2019-02-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101468138 |
| 20207151 | 20077456 | 1.69 | 57 | Palliative (P) | null | 2018-11-09 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100904248 |
| 20207152 | 20077457 | 1.82 | null | Neo-adjuvant (N) | 2019-10-31 | 2019-10-31 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100600229 |
| 20207154 | 20077458 | 1.68 | 49 | 03 | 2018-12-07 | 2018-12-07 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101751562 |
| 20207156 | 20077459 | 1.67 | 70 | null | 2019-09-06 | 2019-09-06 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101449067 |
| 20207159 | 20077460 | 1.7 | 66 | Neo-adjuvant (N) | 2019-02-12 | 2019-02-16 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101611725 |
| 20207160 | 20077461 | 1.81 | 85 | Palliative (P) | 2016-05-01 | 2016-05-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100109022 |
| 20207162 | 20077462 | 0 | 0 | Palliative (P) | 2017-08-25 | 2017-09-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100716337 |
| 20207164 | 20077463 | 1.58 | 110.6 | Palliative (P) | 2019-06-28 | 2019-07-18 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101578988 |
| 20207170 | 20077464 | 1.69 | 85 | Palliative (P) | 2019-11-18 | 2019-11-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101346663 |
| 20207171 | 20077465 | null | null | Palliative (P) | 2020-05-27 | 2020-06-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100394548 |
| 20207176 | 20077466 | 1.67 | 90.55 | null | 2016-07-19 | 2016-07-25 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100557131 |
| 20207177 | 20077467 | 1.77 | 75 | Palliative (P) | 2017-12-20 | 2017-12-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100087174 |
| 20207178 | 20077468 | 1.8 | 72.3 | Palliative (P) | 2018-03-07 | 2018-03-10 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101655943 |
| 20207179 | 20077469 | 1.66 | 56.4 | Palliative (P) | 2017-05-25 | 2017-05-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101760639 |
| 20207186 | 20077470 | 1.62 | 62.2 | Disease modification (D) | 2019-05-26 | 2019-06-07 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101518670 |
| 20207191 | 20077471 | 1.56 | 66 | Palliative (P) | 2016-02-27 | 2016-03-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100831553 |
| 20207192 | 20077472 | 1.61 | 74 | Palliative (P) | 2019-10-31 | 2019-11-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100966523 |
| 20207193 | 20077473 | 1.76 | null | null | 2019-10-15 | 2019-10-15 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100906293 |
| 20207195 | 20077474 | 0 | 0 | Neo-adjuvant (N) | null | 2017-03-27 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100308599 |
| 20207203 | 20077475 | null | null | Neo-adjuvant (N) | 2016-05-29 | 2016-05-29 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100987174 |
| 20207205 | 20077476 | 1.74 | 53.2 | Palliative (P) | 2017-05-21 | 2017-05-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101486808 |
| 20207212 | 20077477 | 1.81 | 90.55 | Curative (C) | 2016-02-19 | 2016-03-04 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100334128 |
| 20207217 | 20077478 | 1.78 | null | Curative (C) | 2017-07-27 | 2017-08-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100151593 |
| 20207218 | 20077479 | 1.55 | 65.3 | Neo-adjuvant (N) | 2016-07-29 | 2016-08-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100414372 |
| 20207222 | 20077480 | null | 114.8 | Palliative (P) | 2019-06-23 | 2019-07-01 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101445810 |